Severity: Warning
Message: fopen(/tmp/ci_session881rnnoct4c0tl1q2id4memapl4fr0hj): failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 9
Function: __construct
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /tmp)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/precisionbusinessinsights.com/application/controllers/User.php
Line: 9
Function: __construct
File: /var/www/precisionbusinessinsights.com/index.php
Line: 315
Function: require_once
Infertility Therapeutics Market: By Drug Class, Biguanides, Others), By Route of Administration , By Gender, By Distribution Channels, and Region Forecast 2020-2031 Â
Report ID:62124
Published Date:Apr 2023
No of Pages:
Format:
| 1. Executive Summary |
| 2. Global Infertility Therapeutics Market Introduction |
| 2.1. Global Infertility Therapeutics Market – Taxonomy |
| 2.2. Global Infertility Therapeutics Market –Definitions |
| 2.2.1. By Drug Class |
| 2.2.2. By Route of Administration |
| 2.2.3. By Gender |
| 2.2.4. By Distribution Channels |
| 2.2.5. By Region |
| 3. Global Infertility Therapeutics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Infertility Therapeutics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Infertility Therapeutics Market – Competition Landscape |
| 4. Global Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Infertility Therapeutics Market, By Drug Class, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1. Gonadotropin |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Aromatase Inhibitors |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Selective Estrogen Receptor Modulators (SERMs) |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Biguanides |
| 5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Infertility Therapeutics Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.1. Oral |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Intravenous |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Subcutaneous |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Intramuscular |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Infertility Therapeutics Market, By Gender, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.1. Men |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Women |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Infertility Therapeutics Market, By Distribution Channels, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Infertility Therapeutics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Region, 2022-2028 |
| 10. North America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 10.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Gonadotropin |
| 10.1.2. Aromatase Inhibitors |
| 10.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 10.1.4. Biguanides |
| 10.1.5. Others |
| 10.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Oral |
| 10.2.2. Intravenous |
| 10.2.3. Subcutaneous |
| 10.2.4. Intramuscular |
| 10.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Men |
| 10.3.2. Women |
| 10.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospital Pharmacies |
| 10.4.2. Retail Pharmacies |
| 10.4.3. Online Pharmacies |
| 10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 10.7. North America Infertility Therapeutics Market Dynamics – Trends |
| 11. Europe Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 11.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Gonadotropin |
| 11.1.2. Aromatase Inhibitors |
| 11.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 11.1.4. Biguanides |
| 11.1.5. Others |
| 11.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Oral |
| 11.2.2. Intravenous |
| 11.2.3. Subcutaneous |
| 11.2.4. Intramuscular |
| 11.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Men |
| 11.3.2. Women |
| 11.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospital Pharmacies |
| 11.4.2. Retail Pharmacies |
| 11.4.3. Online Pharmacies |
| 11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 11.7. Europe Infertility Therapeutics Market Dynamics – Trends |
| 12. Asia-Pacific Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 12.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Gonadotropin |
| 12.1.2. Aromatase Inhibitors |
| 12.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 12.1.4. Biguanides |
| 12.1.5. Others |
| 12.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Oral |
| 12.2.2. Intravenous |
| 12.2.3. Subcutaneous |
| 12.2.4. Intramuscular |
| 12.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Men |
| 12.3.2. Women |
| 12.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospital Pharmacies |
| 12.4.2. Retail Pharmacies |
| 12.4.3. Online Pharmacies |
| 12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, by Drug Class, By Distribution Channels, and Country, 2022-2028 |
| 12.7. Asia-Pacific Infertility Therapeutics Market Dynamics – Trends |
| 13. Latin America Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 13.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Gonadotropin |
| 13.1.2. Aromatase Inhibitors |
| 13.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 13.1.4. Biguanides |
| 13.1.5. Others |
| 13.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Oral |
| 13.2.2. Intravenous |
| 13.2.3. Subcutaneous |
| 13.2.4. Intramuscular |
| 13.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Men |
| 13.3.2. Women |
| 13.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospital Pharmacies |
| 13.4.2. Retail Pharmacies |
| 13.4.3. Online Pharmacies |
| 13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 13.7. Latin America Infertility Therapeutics Market Dynamics – Trends |
| 14. Middle East and Africa Infertility Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 14.1. Drug Class Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Gonadotropin |
| 14.1.2. Aromatase Inhibitors |
| 14.1.3. Selective Estrogen Receptor Modulators (SERMs) |
| 14.1.4. Biguanides |
| 14.1.5. Others |
| 14.2. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Oral |
| 14.2.2. Intravenous |
| 14.2.3. Subcutaneous |
| 14.2.4. Intramuscular |
| 14.3. Gender Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Men |
| 14.3.2. Women |
| 14.4. Distribution Channels Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospital Pharmacies |
| 14.4.2. Retail Pharmacies |
| 14.4.3. Online Pharmacies |
| 14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf CoDistribution Channels Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Infertility Therapeutics Market - Opportunity Analysis Index, By Drug Class, By Route of Administration, By Gender, By Distribution Channels, and Country, 2022-2028 |
| 14.7. MEA Infertility Therapeutics Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key products, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Abbott Laboratories |
| 15.2.2. Takeda Pharmaceutical Company Limited |
| 15.2.3. Ferring Pharmaceuticals Inc. |
| 15.2.4. Pfizer Inc. |
| 15.2.5. Novartis International AG |
| 15.2.6. Bayer AG |
| 15.2.7. Teva Pharmaceticals Industries |
| 15.2.8. Merck & Co., Inc. |
| 15.2.9. Vitrolife AB |
| 15.2.10. MedGyn Products, Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
Latin America
Europe
Asia Pacific
Middle East
North America
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Content Updated Date: Jan 2025
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
